U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542041) titled 'Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens' on April 14.
Brief Summary: The goal of this clinical study is to evaluate whether the NEO-Match(R) test, based on ARTIDIS nanomechanical profiling technology, can help predict treatment outcomes and improve clinical decision-making in patients with suspected pancreatic cancer undergoing biopsy.
The main questions this study aims to answer are:
* Can the NEO-Match(R) test predict how patients respond to neoadjuvant (pre-surgical) treatment for pancreatic cancer?
* How well does the NEO-Match(R) test detect malignant pancreatic lesions compared to standard...